Acute kidney injury induces high-sensitivity troponin measurement changes after cardiac surgery

Amr S Omar1,2,3, Khaled Mahmoud4,5,6, Samy Hanoura7,4,8

  • 1Department of Cardiothoracic Surgery/Cardiac Anaesthesia and ICU, Heart Hospital, Hamad Medical Corporation, Doha, PO 3050, Qatar. a_s_omar@yahoo.com.

BMC Anesthesiology
|February 2, 2017
PubMed

Insights

High-sensitivity troponin T (hsTnT) shows sustained changes in patients with acute kidney injury (AKI) after cardiac surgery, unlike CK-MB. This suggests hsTnT may have delayed clearance in AKI, impacting cardiac risk assessment.

Area of Science:

  • Cardiology
  • Nephrology
  • Biomarkers

Background:

  • Cardiac troponin's utility for cardiac disease risk assessment differs in end-stage renal disease (ESRD) and is understudied in acute kidney injury (AKI).
  • Cardiac surgery is a common cause of AKI, necessitating evaluation of cardiac biomarkers in this context.

Purpose of the Study:

  • To explore the diagnostic value of high-sensitivity troponin T (hsTnT) in patients experiencing cardiac surgery-induced AKI.
  • To compare the behavior of hsTnT and creatine kinase-MB (CK-MB) in patients with and without AKI post-cardiac surgery.

Main Methods:

  • A single-center, observational, retrospective study included 359 patients undergoing cardiac surgery, divided into non-AKI (259 patients) and AKI (100 patients) groups based on AKI Network criteria.
  • Serial measurements of hsTnT and CK-MB were performed. Patients with ESRD were excluded.

Main Results:

  • The AKI group exhibited significantly higher mortality (5% vs. 1.1%), increased incidence of heart failure (17.9% vs. 4.9%), and post-operative atrial fibrillation (12.4% vs. 2.9%).
  • hsTnT showed a significant sustained rise in the AKI group compared to the non-AKI group, whereas CK-MB changes were significant initially but not sustained.
  • Patients with AKI had longer ventilation durations and hospital stays.

Conclusions:

  • hsTnT demonstrates significant, sustained changes throughout the observation period in patients with AKI post-cardiac surgery.
  • These findings suggest a possible delayed clearance of hsTnT in AKI patients, differentiating its behavior from CK-MB and impacting its interpretation as a cardiac risk assessment tool.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.0K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
420
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.0K
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.1K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.0K
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
615